Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Line Development for Biologics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 CHO Cell Lines
1.2.3 HEK293 Cell Lines
1.2.4 Insect Cell Lines
1.3 Market by Application
1.3.1 Global Cell Line Development for Biologics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Monoclonal Antibodies
1.3.3 Recombinant Proteins
1.3.4 Vaccines
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Line Development for Biologics Market Perspective (2018-2033)
2.2 Cell Line Development for Biologics Growth Trends by Region
2.2.1 Global Cell Line Development for Biologics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Cell Line Development for Biologics Historic Market Size by Region (2018-2023)
2.2.3 Cell Line Development for Biologics Forecasted Market Size by Region (2024-2033)
2.3 Cell Line Development for Biologics Market Dynamics
2.3.1 Cell Line Development for Biologics Industry Trends
2.3.2 Cell Line Development for Biologics Market Drivers
2.3.3 Cell Line Development for Biologics Market Challenges
2.3.4 Cell Line Development for Biologics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Line Development for Biologics Players by Revenue
3.1.1 Global Top Cell Line Development for Biologics Players by Revenue (2018-2023)
3.1.2 Global Cell Line Development for Biologics Revenue Market Share by Players (2018-2023)
3.2 Global Cell Line Development for Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell Line Development for Biologics Revenue
3.4 Global Cell Line Development for Biologics Market Concentration Ratio
3.4.1 Global Cell Line Development for Biologics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Line Development for Biologics Revenue in 2022
3.5 Cell Line Development for Biologics Key Players Head office and Area Served
3.6 Key Players Cell Line Development for Biologics Product Solution and Service
3.7 Date of Enter into Cell Line Development for Biologics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Line Development for Biologics Breakdown Data by Type
4.1 Global Cell Line Development for Biologics Historic Market Size by Type (2018-2023)
4.2 Global Cell Line Development for Biologics Forecasted Market Size by Type (2024-2033)
5 Cell Line Development for Biologics Breakdown Data by Application
5.1 Global Cell Line Development for Biologics Historic Market Size by Application (2018-2023)
5.2 Global Cell Line Development for Biologics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Cell Line Development for Biologics Market Size (2018-2033)
6.2 North America Cell Line Development for Biologics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Cell Line Development for Biologics Market Size by Country (2018-2023)
6.4 North America Cell Line Development for Biologics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Line Development for Biologics Market Size (2018-2033)
7.2 Europe Cell Line Development for Biologics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Cell Line Development for Biologics Market Size by Country (2018-2023)
7.4 Europe Cell Line Development for Biologics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Line Development for Biologics Market Size (2018-2033)
8.2 Asia-Pacific Cell Line Development for Biologics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Cell Line Development for Biologics Market Size by Region (2018-2023)
8.4 Asia-Pacific Cell Line Development for Biologics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell Line Development for Biologics Market Size (2018-2033)
9.2 Latin America Cell Line Development for Biologics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Cell Line Development for Biologics Market Size by Country (2018-2023)
9.4 Latin America Cell Line Development for Biologics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Line Development for Biologics Market Size (2018-2033)
10.2 Middle East & Africa Cell Line Development for Biologics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Cell Line Development for Biologics Market Size by Country (2018-2023)
10.4 Middle East & Africa Cell Line Development for Biologics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Detail
11.1.2 Lonza Business Overview
11.1.3 Lonza Cell Line Development for Biologics Introduction
11.1.4 Lonza Revenue in Cell Line Development for Biologics Business (2018-2023)
11.1.5 Lonza Recent Development
11.2 Corning
11.2.1 Corning Company Detail
11.2.2 Corning Business Overview
11.2.3 Corning Cell Line Development for Biologics Introduction
11.2.4 Corning Revenue in Cell Line Development for Biologics Business (2018-2023)
11.2.5 Corning Recent Development
11.3 Sartorius
11.3.1 Sartorius Company Detail
11.3.2 Sartorius Business Overview
11.3.3 Sartorius Cell Line Development for Biologics Introduction
11.3.4 Sartorius Revenue in Cell Line Development for Biologics Business (2018-2023)
11.3.5 Sartorius Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Cell Line Development for Biologics Introduction
11.4.4 Thermo Fisher Scientific Revenue in Cell Line Development for Biologics Business (2018-2023)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Selexis
11.5.1 Selexis Company Detail
11.5.2 Selexis Business Overview
11.5.3 Selexis Cell Line Development for Biologics Introduction
11.5.4 Selexis Revenue in Cell Line Development for Biologics Business (2018-2023)
11.5.5 Selexis Recent Development
11.6 Beckman Coulter (Danaher )
11.6.1 Beckman Coulter (Danaher ) Company Detail
11.6.2 Beckman Coulter (Danaher ) Business Overview
11.6.3 Beckman Coulter (Danaher ) Cell Line Development for Biologics Introduction
11.6.4 Beckman Coulter (Danaher ) Revenue in Cell Line Development for Biologics Business (2018-2023)
11.6.5 Beckman Coulter (Danaher ) Recent Development
11.7 CYTENA
11.7.1 CYTENA Company Detail
11.7.2 CYTENA Business Overview
11.7.3 CYTENA Cell Line Development for Biologics Introduction
11.7.4 CYTENA Revenue in Cell Line Development for Biologics Business (2018-2023)
11.7.5 CYTENA Recent Development
11.8 Molecular Devices
11.8.1 Molecular Devices Company Detail
11.8.2 Molecular Devices Business Overview
11.8.3 Molecular Devices Cell Line Development for Biologics Introduction
11.8.4 Molecular Devices Revenue in Cell Line Development for Biologics Business (2018-2023)
11.8.5 Molecular Devices Recent Development
11.9 Samsung Biologics
11.9.1 Samsung Biologics Company Detail
11.9.2 Samsung Biologics Business Overview
11.9.3 Samsung Biologics Cell Line Development for Biologics Introduction
11.9.4 Samsung Biologics Revenue in Cell Line Development for Biologics Business (2018-2023)
11.9.5 Samsung Biologics Recent Development
11.10 Hera BioLabs
11.10.1 Hera BioLabs Company Detail
11.10.2 Hera BioLabs Business Overview
11.10.3 Hera BioLabs Cell Line Development for Biologics Introduction
11.10.4 Hera BioLabs Revenue in Cell Line Development for Biologics Business (2018-2023)
11.10.5 Hera BioLabs Recent Development
11.11 GTP Bioways
11.11.1 GTP Bioways Company Detail
11.11.2 GTP Bioways Business Overview
11.11.3 GTP Bioways Cell Line Development for Biologics Introduction
11.11.4 GTP Bioways Revenue in Cell Line Development for Biologics Business (2018-2023)
11.11.5 GTP Bioways Recent Development
11.12 Abzena
11.12.1 Abzena Company Detail
11.12.2 Abzena Business Overview
11.12.3 Abzena Cell Line Development for Biologics Introduction
11.12.4 Abzena Revenue in Cell Line Development for Biologics Business (2018-2023)
11.12.5 Abzena Recent Development
11.13 FyoniBio
11.13.1 FyoniBio Company Detail
11.13.2 FyoniBio Business Overview
11.13.3 FyoniBio Cell Line Development for Biologics Introduction
11.13.4 FyoniBio Revenue in Cell Line Development for Biologics Business (2018-2023)
11.13.5 FyoniBio Recent Development
11.14 Catalent
11.14.1 Catalent Company Detail
11.14.2 Catalent Business Overview
11.14.3 Catalent Cell Line Development for Biologics Introduction
11.14.4 Catalent Revenue in Cell Line Development for Biologics Business (2018-2023)
11.14.5 Catalent Recent Development
11.15 WuXi Biologics
11.15.1 WuXi Biologics Company Detail
11.15.2 WuXi Biologics Business Overview
11.15.3 WuXi Biologics Cell Line Development for Biologics Introduction
11.15.4 WuXi Biologics Revenue in Cell Line Development for Biologics Business (2018-2023)
11.15.5 WuXi Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cell Line Development for Biologics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of CHO Cell Lines
Table 3. Key Players of HEK293 Cell Lines
Table 4. Key Players of Insect Cell Lines
Table 5. Global Cell Line Development for Biologics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Cell Line Development for Biologics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Cell Line Development for Biologics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Cell Line Development for Biologics Market Share by Region (2018-2023)
Table 9. Global Cell Line Development for Biologics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Cell Line Development for Biologics Market Share by Region (2024-2033)
Table 11. Cell Line Development for Biologics Market Trends
Table 12. Cell Line Development for Biologics Market Drivers
Table 13. Cell Line Development for Biologics Market Challenges
Table 14. Cell Line Development for Biologics Market Restraints
Table 15. Global Cell Line Development for Biologics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Cell Line Development for Biologics Market Share by Players (2018-2023)
Table 17. Global Top Cell Line Development for Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Line Development for Biologics as of 2022)
Table 18. Ranking of Global Top Cell Line Development for Biologics Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Cell Line Development for Biologics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cell Line Development for Biologics Product Solution and Service
Table 22. Date of Enter into Cell Line Development for Biologics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cell Line Development for Biologics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Cell Line Development for Biologics Revenue Market Share by Type (2018-2023)
Table 26. Global Cell Line Development for Biologics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Cell Line Development for Biologics Revenue Market Share by Type (2024-2033)
Table 28. Global Cell Line Development for Biologics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Cell Line Development for Biologics Revenue Market Share by Application (2018-2023)
Table 30. Global Cell Line Development for Biologics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Cell Line Development for Biologics Revenue Market Share by Application (2024-2033)
Table 32. North America Cell Line Development for Biologics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Cell Line Development for Biologics Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Cell Line Development for Biologics Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Cell Line Development for Biologics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Cell Line Development for Biologics Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Cell Line Development for Biologics Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Cell Line Development for Biologics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Cell Line Development for Biologics Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Cell Line Development for Biologics Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Cell Line Development for Biologics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Cell Line Development for Biologics Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Cell Line Development for Biologics Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Cell Line Development for Biologics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Cell Line Development for Biologics Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Cell Line Development for Biologics Market Size by Country (2024-2033) & (US$ Million)
Table 47. Lonza Company Detail
Table 48. Lonza Business Overview
Table 49. Lonza Cell Line Development for Biologics Product
Table 50. Lonza Revenue in Cell Line Development for Biologics Business (2018-2023) & (US$ Million)
Table 51. Lonza Recent Development
Table 52. Corning Company Detail
Table 53. Corning Business Overview
Table 54. Corning Cell Line Development for Biologics Product
Table 55. Corning Revenue in Cell Line Development for Biologics Business (2018-2023) & (US$ Million)
Table 56. Corning Recent Development
Table 57. Sartorius Company Detail
Table 58. Sartorius Business Overview
Table 59. Sartorius Cell Line Development for Biologics Product
Table 60. Sartorius Revenue in Cell Line Development for Biologics Business (2018-2023) & (US$ Million)
Table 61. Sartorius Recent Development
Table 62. Thermo Fisher Scientific Company Detail
Table 63. Thermo Fisher Scientific Business Overview
Table 64. Thermo Fisher Scientific Cell Line Development for Biologics Product
Table 65. Thermo Fisher Scientific Revenue in Cell Line Development for Biologics Business (2018-2023) & (US$ Million)
Table 66. Thermo Fisher Scientific Recent Development
Table 67. Selexis Company Detail
Table 68. Selexis Business Overview
Table 69. Selexis Cell Line Development for Biologics Product
Table 70. Selexis Revenue in Cell Line Development for Biologics Business (2018-2023) & (US$ Million)
Table 71. Selexis Recent Development
Table 72. Beckman Coulter (Danaher ) Company Detail
Table 73. Beckman Coulter (Danaher ) Business Overview
Table 74. Beckman Coulter (Danaher ) Cell Line Development for Biologics Product
Table 75. Beckman Coulter (Danaher ) Revenue in Cell Line Development for Biologics Business (2018-2023) & (US$ Million)
Table 76. Beckman Coulter (Danaher ) Recent Development
Table 77. CYTENA Company Detail
Table 78. CYTENA Business Overview
Table 79. CYTENA Cell Line Development for Biologics Product
Table 80. CYTENA Revenue in Cell Line Development for Biologics Business (2018-2023) & (US$ Million)
Table 81. CYTENA Recent Development
Table 82. Molecular Devices Company Detail
Table 83. Molecular Devices Business Overview
Table 84. Molecular Devices Cell Line Development for Biologics Product
Table 85. Molecular Devices Revenue in Cell Line Development for Biologics Business (2018-2023) & (US$ Million)
Table 86. Molecular Devices Recent Development
Table 87. Samsung Biologics Company Detail
Table 88. Samsung Biologics Business Overview
Table 89. Samsung Biologics Cell Line Development for Biologics Product
Table 90. Samsung Biologics Revenue in Cell Line Development for Biologics Business (2018-2023) & (US$ Million)
Table 91. Samsung Biologics Recent Development
Table 92. Hera BioLabs Company Detail
Table 93. Hera BioLabs Business Overview
Table 94. Hera BioLabs Cell Line Development for Biologics Product
Table 95. Hera BioLabs Revenue in Cell Line Development for Biologics Business (2018-2023) & (US$ Million)
Table 96. Hera BioLabs Recent Development
Table 97. GTP Bioways Company Detail
Table 98. GTP Bioways Business Overview
Table 99. GTP Bioways Cell Line Development for Biologics Product
Table 100. GTP Bioways Revenue in Cell Line Development for Biologics Business (2018-2023) & (US$ Million)
Table 101. GTP Bioways Recent Development
Table 102. Abzena Company Detail
Table 103. Abzena Business Overview
Table 104. Abzena Cell Line Development for Biologics Product
Table 105. Abzena Revenue in Cell Line Development for Biologics Business (2018-2023) & (US$ Million)
Table 106. Abzena Recent Development
Table 107. FyoniBio Company Detail
Table 108. FyoniBio Business Overview
Table 109. FyoniBio Cell Line Development for Biologics Product
Table 110. FyoniBio Revenue in Cell Line Development for Biologics Business (2018-2023) & (US$ Million)
Table 111. FyoniBio Recent Development
Table 112. Catalent Company Detail
Table 113. Catalent Business Overview
Table 114. Catalent Cell Line Development for Biologics Product
Table 115. Catalent Revenue in Cell Line Development for Biologics Business (2018-2023) & (US$ Million)
Table 116. Catalent Recent Development
Table 117. WuXi Biologics Company Detail
Table 118. WuXi Biologics Business Overview
Table 119. WuXi Biologics Cell Line Development for Biologics Product
Table 120. WuXi Biologics Revenue in Cell Line Development for Biologics Business (2018-2023) & (US$ Million)
Table 121. WuXi Biologics Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell Line Development for Biologics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Cell Line Development for Biologics Market Share by Type: 2022 VS 2033
Figure 3. CHO Cell Lines Features
Figure 4. HEK293 Cell Lines Features
Figure 5. Insect Cell Lines Features
Figure 6. Global Cell Line Development for Biologics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Cell Line Development for Biologics Market Share by Application: 2022 VS 2033
Figure 8. Monoclonal Antibodies Case Studies
Figure 9. Recombinant Proteins Case Studies
Figure 10. Vaccines Case Studies
Figure 11. Cell Line Development for Biologics Report Years Considered
Figure 12. Global Cell Line Development for Biologics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Cell Line Development for Biologics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Cell Line Development for Biologics Market Share by Region: 2022 VS 2033
Figure 15. Global Cell Line Development for Biologics Market Share by Players in 2022
Figure 16. Global Top Cell Line Development for Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Line Development for Biologics as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Cell Line Development for Biologics Revenue in 2022
Figure 18. North America Cell Line Development for Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Cell Line Development for Biologics Market Share by Country (2018-2033)
Figure 20. United States Cell Line Development for Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Cell Line Development for Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Cell Line Development for Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Cell Line Development for Biologics Market Share by Country (2018-2033)
Figure 24. Germany Cell Line Development for Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Cell Line Development for Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Cell Line Development for Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Cell Line Development for Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Cell Line Development for Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Cell Line Development for Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Cell Line Development for Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Cell Line Development for Biologics Market Share by Region (2018-2033)
Figure 32. China Cell Line Development for Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Cell Line Development for Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Cell Line Development for Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Cell Line Development for Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Cell Line Development for Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Cell Line Development for Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Cell Line Development for Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Cell Line Development for Biologics Market Share by Country (2018-2033)
Figure 40. Mexico Cell Line Development for Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Cell Line Development for Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Cell Line Development for Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Cell Line Development for Biologics Market Share by Country (2018-2033)
Figure 44. Turkey Cell Line Development for Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Cell Line Development for Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Lonza Revenue Growth Rate in Cell Line Development for Biologics Business (2018-2023)
Figure 47. Corning Revenue Growth Rate in Cell Line Development for Biologics Business (2018-2023)
Figure 48. Sartorius Revenue Growth Rate in Cell Line Development for Biologics Business (2018-2023)
Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Cell Line Development for Biologics Business (2018-2023)
Figure 50. Selexis Revenue Growth Rate in Cell Line Development for Biologics Business (2018-2023)
Figure 51. Beckman Coulter (Danaher ) Revenue Growth Rate in Cell Line Development for Biologics Business (2018-2023)
Figure 52. CYTENA Revenue Growth Rate in Cell Line Development for Biologics Business (2018-2023)
Figure 53. Molecular Devices Revenue Growth Rate in Cell Line Development for Biologics Business (2018-2023)
Figure 54. Samsung Biologics Revenue Growth Rate in Cell Line Development for Biologics Business (2018-2023)
Figure 55. Hera BioLabs Revenue Growth Rate in Cell Line Development for Biologics Business (2018-2023)
Figure 56. GTP Bioways Revenue Growth Rate in Cell Line Development for Biologics Business (2018-2023)
Figure 57. Abzena Revenue Growth Rate in Cell Line Development for Biologics Business (2018-2023)
Figure 58. FyoniBio Revenue Growth Rate in Cell Line Development for Biologics Business (2018-2023)
Figure 59. Catalent Revenue Growth Rate in Cell Line Development for Biologics Business (2018-2023)
Figure 60. WuXi Biologics Revenue Growth Rate in Cell Line Development for Biologics Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed